Hana Višňová

Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial

Anders Nyboe Andersen, Scott M. Nelson, Bart C.J.M. Fauser et al. · Fertility and Sterility · 2016 · 273 citations · Full text

Fertility, Reproductive Health, Gynecology +7

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone–stratified, dose–response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection

Joan‐Carles Arce, Anders Nyboe Andersen, Manuel Fernández Sánchez et al. · Fertility and Sterility · 2014 · 184 citations · Full text

Ascorbic acid and infertility treatment.

I Crha, Drahoslava Hrubá, Pavel Ventruba et al. · PubMed · 2003 · 70 citations

Individualization of the starting dose of follitropin delta reduces the overall OHSS risk and/or the need for additional preventive interventions: cumulative data over three stimulation cycles

Manuel Fernández Sánchez, Hana Višňová, Albert Yuzpe et al. · Reproductive BioMedicine Online · 2018 · 42 citations · Full text

A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol

Manuel Fernández Sánchez, Hana Višňová, Per Larsson et al. · Human Reproduction · 2022 · 23 citations · Full text